Health
Japan warns of a rise in potentially fatal cases of sore throat
Health authorities in Japan have warned of a sharp rise in potentially fatal sore throat infections, with the number of cases in Tokyo about three
Regeneron blood cancer treatment faces setback
Regeneron Pharmaceuticals said Monday that the U.S. FDA has rejected approval for a blood cancer treatment for two forms of lymphoma because of concerns about
Wipro GE Healthcare to invest $960m in research
Wipro GE Healthcare, a joint venture of India’s Wipro Enterprises and a wholly owned subsidiary of US-based GE Healthcare said it will invest 80 billion
AbbVie to strengthen production of immune disease drugs through Lando deal
AbbVie will buy drug developer Landos Biopharma for up to $212 million as the Humira maker seeks to expand its line of medicines to treat
South Korean medical professors join protests and cut practice hours
Medical professors in South Korea said they will cut the hours they spend in practice starting Monday to support trainee doctors on strike for more
Regeneron’s blood cancer therapy suffers setback
Regeneron Pharmaceuticals said the US FDA has rejected approval of its blood cancer therapy for two forms of lymphoma, raising concerns about the progress of
US notifies BioNTech of non-payment of royalties for COVID vaccine
BioNTech said the US National Institutes of Health has sent a notice to BioNTech regarding non-payment of royalties and other amounts related to its COVID-19
New Zealand government to ban disposable e-cigarettes
The New Zealand government said on Wednesday it would ban the sale of disposable e-cigarettes, increase fines for retailers selling them to under-18s and improve
EU lawmakers vote to extend exclusivity period for new medicines
Lawmakers in an EU parliamentary committee voted on Tuesday to extend the exclusivity period for new medicines from the original draft, seeking to address concerns
French biotech company Valneva raises sales forecast for its products
French biotech company Valneva on Wednesday raised its product sales forecast and said it now expects revenue of 170 million to 190 million euros ($184.72